A method utilizing reversed-phase high-performance liquid chromatography has been developed for the purification to homogeneity of interleukin 2 (IL-2) isolated from a human T-cell leukemia. A rmal purification of 500,000-fold was obtained with a specific activity of pure IL-2 of 10' units/mg. The amino acid analysis of natural IL-2 is strikingly similar to the composition deduced from sequence analysis of a cDNA coding for human IL-2. Protein sequence analysis of CNBr-derived peptides yields data consistent with the sequence proposed from cloned cDNA. The availability of homogeneous IL-2 will allow accurate biological studies of its activity free from the contamination of the numerous lymphokine species that are known to be co-produced with IL-2 during the induction procedure.
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Interleukin 2 (IL-2), formerly known as T-cell growth factor, was first described as a lymphokine capable of modulating lymphocyte reactivity and promoting the long-term in vitro culture of antigen-specific effector T lymphocytes (1, 2) . IL-2 partially purified from mouse (3, 4) , rat (5, 6) , and human (7, 8) normal T lymphocytes has been found to retain different types of biological activity, including: (i) marked enhancement of thymocyte mitogenesis (7, 9) ; (ii) promotion of long-term in vitro proliferation of antigen-specific helper or killer T-cell lines (3, 10) ; and (iii) induction of cytotoxic Tlymphocyte reactivity and plaque-forming cell responses in cultures of nude mouse spleen cells (7, 9) . These activities indicate that IL-2 may be useful in augmenting immune responses and restoring immune-deficient T-cell populations (nude mouse spleen cells) to normal levels of cellular and humoral immunity. Furthermore, these results suggest that IL-2 production and response are important parameters of immunological functions and their measurement may be useful in clinical diagnosis of aberrant immune status.
The sources and techniques that have been used to produce IL-2 have yielded low concentrations of IL-2, with large volumes of conditioned media being required to obtain only small quantities of human IL-2 activity. As a consequence, sufficient quantities of concentrated human IL-2 have not been available for in vivo experiments or for its characterization. Several groups have reported purification procedures for both murine (9, 11) and human (7, (12) (13) (14) IL-2, although the purity of these preparations is not clear. The present study reports a procedure for the purification of human IL-2 to homogeneity using several steps of reversed-phase high-performance liquid chromatography (HPLC) . Chemical characterization of the purified lymphokine is reported.
EXPERIMENTAL PROCEDURES
Source of IL-2. Human leukemia T cells designated Jurkat-H33HJ-JAI (a subclone of the parent Jurkat-FHC1C cell line) (15) were maintained in RPMI 1640 medium supplemented with 10% fetal calf serum, 50 units of penicillin per ml, 50 ug of gentamycin per ml, and 300 .g of fresh L-glutamine per ml. The cells were grown in T175-cm2 flasks (volume, 150 ml) in a humidified atmosphere of 5% CO0 in air until saturation (8-10 x 105 cell per ml); they then were harvested, pelleted, and resuspended (in fresh RPMI 1640 medium without serum but with 50 units of penicillin per ml, 50 jg of streptomycin per ml, 50 pug of gentamycin per rhl, and 300 pug offresh L-glutamine per ml) to a concentration of 2 x 106 cells per ml in fresh T175-cm2 flasks. For IL-2 production, the cells were stimulated with the T-cell mitogen phytohemagglutinin M (PHA-M; GIBCO; 1% by volume) and phorbol 12-myristate 13-acetate (PMA; Sigma; at a final concentration of 10 ng/ml) (15) . After 24 hr of incubation at 370C in a humidified atmosphere of 5% CO2 in air, the suspensions were centrifuged for 15 min at 1000 x g at 40C, and the resultant supernatant solution was retained as crude conditioned medium. For the purification detailed in Table 1 , a total of 50 liters of crude conditioned media was prepared. Despite the fact that such crude supernates were produced serum-free, they contained a relatively large amount of protein (=-1 mg/ml) due to prior growth of the producer cells in serum, the presence of 1% PHA (crude mitrogen) in the supernatant solutions, and the liberation of cellular protein into the culture fluid due to death of the Jurkat-H33HJ-JAI cells upon mitogen stimulation (15) .
Ammonium Sulfate Precipitation. Crude human IL-2 supernatant solutions prepared from several batches of induced H33HJ-JAI cells were pooled and brought to 35% saturation by adding solid ammonium sulfate at 40C. The solution was kept at 40C overnight and then was centrifuged at 10,000 x g for 30 min. The precipitate was discarded and the supernatant solution was brought to 85% saturation by the addition of solid ammonium sulfate at 40C. The precipitate was isolated by centrifugation at 10,000 x g for 20 min, dissolved in sterile double-distilled water, and dialyzed against 1,000 vol of 0.05 M NaCl/Hepes (25 
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Combined dialyzed solutions of ammonium sulfate-precipitated protein (see above) were applied to a CM column. The column was first washed with 2 vol of 0.05 M NaCl/Hepes (25 mM), pH 5.5, and then eluted with a 500-ml salt gradient from 50 mM to 0.5 M NaCl/Hepes (25 mM), pH 5.5.
Reversed-Phase HPLC. The chromatographic system was described previously (16) . An automated fluorescence detection system using fluorescamine (Hoffmann-La Roche) monitored the protein in the column effluents (17) . Reversed fluorescence was again obtained upon this rechromatography, indicating a homogeneous preparation (Fig. 2B) . Recovery of activity in this step was >60%6. Amino acid analysis was performed on each of the fractions within the peak area to confirm the homogeneity of the polypeptide (see below). Finally, essential homogeneity of this material was confirmed by analytical NaDodSO4/polyacrylamide gel electrophoresis and two-dimensional gel electrophoresis, which yielded a single band (Mr 14,000) and a single spot, respectively (data not shown).
The overall purification of IL-2 that was achieved is shown in Table 1 . The protein content of the Vydac C18-and Protesil diphenyl-purified material was calculated on the basis of the amino acid analysis. A specific activity of 109 units/mg of protein and a final purification of 500,000-fold were obtained. The overall recovery of IL-2_was -36%.
Chemical Characterization. The ability to prepare homogeneous IL-2 allowed for the determination of the amino acid composition and partial sequence analysis of the naturally occurring IL-2 protein. The fractions containing pure IL-2 (4 ml) (Fig. 2B) were diluted with the acetate/pyridine buffer (1:1, vol/vol) and applied to a previously unused diphenyl column. By "pulsing" the protein off the column with 60% 1-propanol in the acetate/pyridine buffer at a slow flow rate, the volume was reduced to 0.5 ml. Chemical characterizations were carried out on this solution of IL-2. - The protein was subjected to carboxymethylation, and its amino acid composition was determined before and after the procedure (Table 2 ). Simultaneous to the preparation of this report, Taniguchi et al. reported the cloning and sequence analysis of a cDNA coding for human IL-2 (25) , from which the primary structure of the mature human IL-2 polypeptide was deduced assuming cleavage of the signal peptide at position 20. The amino acid composition of this structure is shown in Table 2 . A comparison of the composition of the naturally occurring protein and the deduced IL-2 shows them to be strikingly similar.
Amino-terminal sequence determination of the IL-2 polypeptide was attempted on 300 pmol by automated Edman degradation. Analysis of the first few cycles yielded no sequence data, suggesting a possible amino-terminal substitution.
To obtain sequence data, carboxymethylated IL-2 was cleaved with CNBr and was subjected to HPLC. The re- Samples (20-30 pmol) were hydrolyzed at 110°C for 22 hr in 100 Al of constant-boiling HCO containing 2.0% thioglycolic acid. Tryptophan was not determined (ND). The results represent means of nine analyses, except for proline and carboxymethylcysteine, which are means of three analyses each. By the method used, the value for proline may be >20% inaccurate (24) . Values in parentheses represent the theoretical amino acid composition of IL-2 based upon the primary structure of the protein deduced from sequence analysis of cloned IL-2 cDNA (25). to the reversed-phase column. In addition, because this fragment does not contain any lysine residues, it may not react well in the postcolumn fluorescamine detection system.
The amino-terminal sequence of fragment C-1 was determined by automated Edman degradation on 100 pmol of the peptide. Unambiguous results were obtained for the first 14 cycles, with an initial yield of 35%, and the residue assignments were as follows: NH2-Ile-Leu-Asn-Gly-Ile-Asn-AsnTyr-Lys-Asn-Pro-Lys-Leu-Thr. This sequence is the same as position 44-57 of the sequence proposed by Taniguchi et al. from cloned human IL-2 cDNA (25). DISCUSSION IL-2, since its initial use for the growth and maintenance of heterogeneous and cloned T-cell lines in vitro (2, 3, 26) , has become both an important research tool and a molecule of keen interest to immunologists and cell biologists. It has also been used to stimulate the growth of many types of antigenreactive human and murine T-cell lines (10, 27) . Since these initial publications, the use of IL-2 as a reagent for in vitro culture of killer, helper, and suppressor T cells has become common.
Biochemically characterized IL-2 has been shown to augment a number of in vitro immune responses, including the generation of antigen-specific cytotoxic T cells (28) , the lytic activity of natural killer cells (29) , and the development of plaque-forming B cells (9) . Likewise, lymphokines or other modifiers that augment T-cell responses have been shown to do so in many instances by facilitating IL-2 production (30) (31) (32) . Based on the pivotal role that IL-2 has been shown to play regarding T-cell proliferation, this lymphokine may also manipulate in vivo immune responses as a natural mediator of immunity (33, 34) .
These data, together with the potential of using IL-2-driven T cells as therapeutic tools, have served to increase scientific interest surrounding IL-2. Attempts to chemically characterize IL-2 progressed rapidly due to the development of advanced separation techniques, such as HPLC, cloned cel- the resultant peptides were separated by HPLC on a Supelcosil LC-18-DB column (particle size, 3 ,um; 4.6 x 150 mm). Elution was carried out using a linear gradient of acetonitrile (---) in 0.1% trifluoroacetic acid at a flow rate of 20 ml/hr. Five percent of the column effluent was diverted to the detection system. CNBr peptides are numbered according to their elution position. lular sources of the lymphokine (15, 35) , and the standardization of an unequivocal bioassay for the detection of IL-2 based on its ability to trigger the proliferation of cloned responsive T cells (5) . The availability of the homogeneous IL-2 will now permit biological studies of its activity free from the contamination of impurities and related substances, such as inducing agents and lymphokines, that are known to be coproduced with IL-2 during the induction procedure. There have been earlier reports of highly purified or nearly homogeneous IL-2 preparations based on the appearance of a single band on NaDodSO4/polyacrylamide gel electrophoresis (6, 8, 14) . However, we have found that when material prepared by those procedures is chromatographed by HPLC, it can generally be resolved into several protein peaks, most of which are not associated with the IL-2 activity. As an example, previous reports have referred to a coelution of B-cell growth factor with IL-2 under various chromatographic conditions (36, 37) . However, the homogeneous IL-2 contains no detectable B-cell growth factor bioactivity, as measured by its inability to provide a proliferative signal to anti-pu-stimulated human peripheral blood B lymphocytes (unpublished data).
An interesting structural feature of the IL-2 molecule is its high content of leucine residues; >13% of the amino acids comprising IL-2 are leucine residues. In fact, the IL-2 amino acid composition reveals it to be a hydrophobic molecule, which is in accord with its observed elution off reversedphase supports (Fig. 2) . This hydrophobic nature is probably important in the molecule's biological activity in relation to receptor binding and interaction.
Concurrent with the preparation of this report, Taniguchi et al. (25) described a cDNA coding for human IL-2 that had been cloned from a cDNA library prepared from partially purified IL-2 mRNA. The DNA sequence codes for a polypeptide that consists of 153 amino acids including a putative signal sequence. This accomplishment will foster IL-2 research as investigators study the mechanism behind IL-2 gene regulation and expression.
The potential supply of sufficient quantities of pure human IL-2 for use by immunologists and cell biologists who are interested in studying the induction of T-cell proliferation as a model of cell division and differentiation remains a question of chemical purification. This is so whether the source of the material is prepared by bacterial fermentation or by cell culture. The biochemical separation procedures outlined above permit the rapid, efficient purification of human IL-2. These techniques together with appropriate affinity chromatographic procedures may be used to purify both recombinant and naturally produced human IL-2 for biological investigation.
